Business

Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health

System Innovations Improve Efficiencies for Healthcare Practices and Patients MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:

articleNeuronetics, Inc.October 19, 20215/company/neuronetics-inc/news/neuronetics-launches-upgrades-of-neurostarr-advanced-therapy-for-mental-health
Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health

About this update from Neuronetics, Inc.

[{"type":"text","content":"System Innovations Improve Efficiencies for Healthcare Practices and Patients MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders announced today the release of the latest evolution of their NeuroStar® Advanced Therapy system with upgraded equipment and features. NeuroStar® Advanced Therapy for Mental Health is the leading transcranial magnetic stimulation (TMS) treatment for major depressive disorder with over 4 million treatments delivered and thousands of lives transformed. In addition to a refreshed look, the NeuroStar and TrakStar® enhancements will allow healthcare professionals (HCPs) to streamline their ability to treat more patients. “This advancement of the NeuroStar Advanced Therapy system underscores our commitment to our NeuroStar providers, their patients, and our mission to transform neurohealth and depression,” said Keith Sullivan, President and CEO of Neuronetics Inc. “Our new TrakStar updates will simultaneously simplify the process and improve the usability for providers so more of their patients can benefit from NeuroStar treatment, a proven method to help people who are living with depression.” Included in the update is an improved motor threshold (MT) algorithm, Fast MT™, which reduces the number of steps to determine the recommended MT level, one of the key treatment settings. Clinicians can also automate the treatment pulse ramping profile with SoftStart™, which allows HCPs to easily add or remove a sequence of pulses during a treatment session to ramp to the prescribed treatment level. In addition, TrakStar upgrades will enable HCPs to electronically request a benefits investigation (BI) for new potential patients and then manage and view BI results directly from NeuroStar’s proprietary HIPAA-compliant TrakStar patient data management system. TrakStar, which was designed to increase productivity, safety and practice marketing, is an essential tool that helps practices manage patients throughout their treatment course and track their patient outcomes. It helps optimize time spent with patients and decreases time spent on paperwork and other administrative tasks. “In my eleven years as a NeuroS...

More updates from Neuronetics, Inc.